Cardiff Oncology (CRDF) Other Non-Current Liabilities (2011 - 2021)
Cardiff Oncology's Other Non-Current Liabilities was $30,000 in Q3 2021, down 84.2% from $190,199 a year earlier and down 86.0% from the prior quarter.
Powered by 
Analysis
Cardiff Oncology (CRDF) Other Non-Current Liabilities (2011 - 2021) Analysis & Trends
At the end of FY2020, Other Non-Current Liabilities at Cardiff Oncology came in at $285,000, up 122.0% from FY2019.
- Other Non-Current Liabilities shows a five-year compound annual growth rate of -38.7% (FY2015 to FY2020).
- In earlier years, Other Non-Current Liabilities was $128,368 in FY2019 (-88.2%), $1.09 million in FY2018 (-7.9%), $1.18 million in FY2017 (-13.8%) and $1.37 million in FY2016 (-58.3%).
- The Q3 2021 figure marks the lowest quarterly Other Non-Current Liabilities since Q3 2019.
- Compared with a year earlier, Other Non-Current Liabilities was higher in five of the last seven quarters, with growth averaging 101.3%.
- The best year-over-year quarter for Other Non-Current Liabilities over five years was Q2 2020 (growth of 297.6%); the worst was Q3 2019 (a decline of 99.6%).
- Per Business Quant data, CRDF's Other Non-Current Liabilities in the three quarters before Q3 2021 was $214,000 (Q2 2021), $191,000 (Q1 2021) and $285,000 (Q4 2020).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Cardiff Oncology | 63.71 Mn | 29.21 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | 35,000.00 |
| Jun 30, 2021 | 231,000.00 |
| Mar 31, 2021 | 269,000.00 |
| Dec 31, 2020 | 441,000.00 |
| Sep 30, 2020 | 278,651.00 |
| Jun 30, 2020 | 118,865.00 |
| Mar 31, 2020 | 141,064.00 |
| Dec 31, 2019 | 132,495.00 |
| Sep 30, 2019 | 4,956.00 |
| Jun 30, 2019 | 18,287.00 |
| Mar 31, 2019 | 42,076.00 |
| Dec 31, 2018 | 1.16 Mn |
| Sep 30, 2018 | 1.27 Mn |
| Jun 30, 2018 | 1.07 Mn |
| Mar 31, 2018 | 1.88 Mn |
| Dec 31, 2017 | 1.83 Mn |
| Sep 30, 2017 | 3.19 Mn |
| Jun 30, 2017 | 1.59 Mn |
| Mar 31, 2017 | 1.59 Mn |
| Dec 31, 2016 | 2.21 Mn |
API Access
Cardiff Oncology Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=CRDF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "CRDF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=CRDF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();